EWG Elevate’s HCA Healthcare HCA Stock Holding History

EWG Elevate’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2	Closed	-$480	–	344
2022 Q4	$480	Buy	+2	New	+$448	﹤0.01%	747

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

EWG Elevate's HCA Position: Q1 2023 in Review

EWG Elevate sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 2 shares — an estimated $480 sold.

EWG Elevate first reported a position in HCA in Q4 2022 and held it in 1 quarter. The position peaked at $480 in Q4 2022. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

EWG Elevate reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 2 HCA Healthcare shares in Q1 2023, an estimated $480.
EWG Elevate first reported a position in HCA Healthcare in Q4 2022 and held it in 1 quarter.
EWG Elevate's HCA Healthcare position peaked at $480 in Q4 2022.
970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.